Higi, a US-based health screening services provider that counts health insurer Blue Cross Blue Shield Association as a backer, has raised $21.3m in series C funding.
The capital was provided by a mix of existing and new investors, though the company only specifically named venture capital firm Flare Capital Partners and VC fund 7wireVentures as participants.
Higi has built a repository of standardised biometric data garnered through more than 11,000 self-screening stations installed in public locations such as pharmacies. The data helps healthcare providers target specific consumer groups and collect biometric information.
The company secured $40m in an early 2016 round funded by undisclosed investors, before BlueCross BlueShield Venture Partners, the corporate venturing arm of Blue Cross Blue Shield Association, provided an undisclosed amount of series B funding in March 2017.
Jeff Bennett, Higi CEO, said: “This is an exciting time for our company to grow with our healthcare customers, and help healthcare systems improve consumer engagement, close gaps in care, lower costs and ultimately improve outcomes.”